Fact: When interest rates rise, you need to be in dividend-growth stocks.
Proof: They’ve handily beaten the S&P 500 in the 17 months since the Federal Reserve put the zero-interest-rate era on ice.
In just a moment, I’ll show you 2 terrific off-the-radar dividend-growth plays to snap up now—and 2 surprising blue chips you’ll want to keep well away from your nest egg.
First, take a look at how the iShares Core Dividend-Growth ETF (DGRO) has performed vs. the SPDR S&P 500 ETF (SPY) on a total-return basis since December 16, 2015, the day Janet Yellen raised rates for the first time in nine years.
The Dividend-Growth Edge in 1 Chart
Best Blue Chip Stocks To Invest In 2019: W&T Offshore Inc.(WTI)
- [By Lisa Levin]
On Wednesday, the energy sector proved to be a source of strength for the market. Leading the sector was strength from SM Energy Co (NYSE: SM) and W&T Offshore, Inc. (NYSE: WTI).
- [By Lee Jackson]
W&T Offshore Inc. (NYSE: WTI) had a big buy hit the tape last week. CEO Tracy Krohn picked up a massive 1,180,888 shares of the independent oil and natural gas producer at $1.94 per share. The total for the trade came in right at the $2 million level.The company engages in the acquisition, exploration and development of oil and natural gas properties in the Gulf of Mexico. The stock closed Friday at $2.67, so outstanding timing, indeed.
- [By John Bromels]
Shares of oil and gas drillerW&T Offshore(NYSE:WTI) fell throughout April, finishing the month at $2.04 per share, down 26.4%.
W&T is a small company primarily focused on natural gas liquids production in the Gulf of Mexico. In April, its market cap dropped about $100 million to $280 million. Huge swings like that aren’t uncommon for small companies, but what was unusual was the apparent lack of rationale for the drop.
Best Blue Chip Stocks To Invest In 2019: Wabash National Corporation(WNC)
- [By Travis Hoium]
Shares of Wabash National Corporation (NYSE:WNC) jumped 10.1% in April, according to data provided by S&P Global Market Intelligence, after the company reported its first-quarter 2017 results.
Best Blue Chip Stocks To Invest In 2019: NewStar Financial, Inc.(NEWS)
- [By Lisa Levin] Related AHT 25 Biggest Mid-Day Gainers For Friday Mid-Day Market Update: Hortonworks Drops Following Weak Results; Freshpet Shares Spike Higher Ashford Hospitality Trust's (AHT) CEO Montgomery Bennet on Q2 2016 Results – Earnings Call Transcript (Seeking Alpha)
Related NEWS Mid-Morning Market Update: Markets Open Higher; Micron To Lower Jobs Mid-Morning Market Update: Markets Open Lower; Broadcom Profit Beats Expectations NewStar Financial's (NEWS) CEO Tim Conway on Q2 2016 Results – Earnings Call Transcript (Seeking Alpha)
Best Blue Chip Stocks To Invest In 2019: SteadyMed Ltd.(STDY)
- [By Lisa Levin]
Pyxis Tankers Inc. (NYSE: PXS) rose 47.48 percent to $$5.56, after the company announced it has entered into a definitive securities purchase agreement with a group of investors, which will result in gross proceeds of $4.8 million.
Sigma Designs Inc (NASDAQ: SIGM) rose 22.77 percent to $6.88. Silicon Laboratories (NASDAQ: SLAB) announced plans to buy Sigma Designs for $7.05 per share in cash.
Steadymed Ltd (NASDAQ: STDY) rose 19.35 percent to $3.70, after the company reported that no clinical trials were required for Trevyent and that the FDA had agreed to the pathway for the drug candidate's NDA resubmission.
Iteris, Inc. (NASDAQ: ITI) rose 15.73 percent to $7.06. Earlier in the week, Zacks Investment Research had upgraded the company from "Sell" to "Hold".
Science Applications International Corp (NYSE: SAIC) rose 13.71 percent to $85.77 as the company reported better-than-expected earnings for its third quarter.
Technical Communications Corporation (NASDAQ: TCCO) rose 12.41 percent to $6.07, after having risen sharply in pre-marketing trading.
Radius Health, Inc. (NASDAQ: RDUS) rose 12.41 percent to $30.81 after the company provided an update on data from the Phase 1 005 clinical study of elacestrant in patients with estrogen receptor positive breast cancer during the 2017 San Antonio Breast Cancer Symposium.
ForeScout Technologies, Inc. (NASDAQ: FSCT) rose 12.32 percent to $25.80 after the company reported its third quarter financial results.
Prana Biotechnology Limited (NASDAQ: PRAN) rose 11.36 percent to $3.43, as the company announced a research collaboration with Takeda Pharmaceuticals to study the ability of movement disorders compound, PBT434 to slow or prevent neurodegeneration of the gastrointestinal system.
Catalyst Biosciences, Inc. (NASDAQ: CBIO) rose 10.49 percent to $7.90 as the company announced the appointment of Arwa Shurrab and Jamie Ellen Siegel in its clinical hemophilia